Genesis and regulation of C-terminal cyclic imides from protein damage
Proceedings of the National Academy of Sciences · 2025
DOI: 10.1073/pnas.2415976121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Wenqing Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138. Hauptthemen laut MEDLINE: Protein Processing, Post-Translational. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, HHS | National Institutes of Health (NIH).
Abstract (Originalsprache)
C-Terminal cyclic imides are posttranslational modifications that can arise from spontaneous intramolecular cleavage of asparagine or glutamine residues resulting in a form of irreversible protein damage. These protein damage events are recognized and removed by the E3 ligase substrate adapter cereblon (CRBN), indicating that these aging-related modifications may require cellular quality control mechanisms to prevent deleterious effects. However, the factors that determine protein or peptide susceptibility to C-terminal cyclic imide formation or their effect on protein stability have not been explored in detail. Here, we characterize the primary and secondary structures of peptides and proteins that promote intrinsic formation of C-terminal cyclic imides in comparison to deamidation, a related form of protein damage. Extrinsic effects from solution properties and stressors on the cellular proteome additionally promote C-terminal cyclic imide formation on proteins like glutathione synthetase that are susceptible to aggregation if the protein damage products are not removed by CRBN. This systematic investigation provides insight into the regions of the proteome that are prone to these unexpectedly frequent modifications, the effects of this form of protein damage on protein stability, and the biological role of CRBN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138.
- Novo Nordisk R&D US, Lexington, MA 02421.
ORCID-Profile: Wenqing Xu, Christina M Woo
Förderung
- NIGMS NIH HHS
- HHS | National Institutes of Health (NIH)
Zitieren
APA
Xu, W., Zhao, Z., Su, M., Jain, A. D., Lloyd, H. C., Feng, E. Y., Cox, N., & Woo, C. M. (2025). Genesis and regulation of C-terminal cyclic imides from protein damage. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2415976121
Vancouver
Xu W, Zhao Z, Su M, Jain AD, Lloyd HC, Feng EY, et al. Genesis and regulation of C-terminal cyclic imides from protein damage. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2415976121
BibTeX
@article{Xu2025,
author = {Xu, Wenqing and Zhao, Zhenguang and Su, Matthew and Jain, Atul D and Lloyd, Hannah C and Feng, Ethan Yang and Cox, Nick and Woo, Christina M},
title = {Genesis and regulation of C-terminal cyclic imides from protein damage},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
doi = {10.1073/pnas.2415976121}
}
EUVIMED